Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks-Reference-Cited by-同舟云学术

Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks

Published:2017-02-14 Issue:5 Volume:125 Page:303-312
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathology

Author:

Zito Marino Federica¹²,Rossi Giulio³,Brunelli Matteo⁴,Malzone Maria Gabriella¹,Liguori Giuseppina¹,Bogina Giuseppe⁵,Morabito Alessandro⁶,Rocco Gaetano⁷,Franco Renato²,Botti Gerardo¹

Affiliation:

1. Pathology Unit, Istituto Nazionale Tumori Fondazione G. Pascale; Naples Italy

2. Pathology Unit; Luigi Vanvitelli University of Campania; Naples Italy

3. Unit of Pathologic Anatomy, Azienda USL Valle d'Aosta; Aosta Italy

4. Anatomic Pathology Section Department of Pathology; University of Verona; Verona Italy

5. Section of Pathologic Anatomy, Sacro Cuore Don Calabria Hospital; Negrar Italy

6. Medical Oncology Unit, Department of Thoracic Surgical and Medical Oncology, Istituto Nazionale Tumori Fondazione G. Pascale; Naples Italy

7. Division of Thoracic Surgery; Department of Thoracic Surgical and Medical Oncology, Istituto Nazionale Tumori Fondazione G. Pascale; Naples Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference85 articles.

1. Lung cancer in the era of targeted therapy: a cytologist's perspective;Zakowski;Arch Pathol Lab Med.,2013

2. Travis WD Brambilla E Muller-Hermelink HK Harris CC Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart 2004

3. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory international multidisciplinary classification of lung adenocarcinoma;Travis;J Thorac Oncol.,2011

4. Targeted therapy management in NSCLC patients using cytology: experience from tertiary care cancer center;Veldore;Mol Diagn Ther.,2016

5. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology;Lindeman;J Mol Diagn.,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multitarget Fluorescence In Situ Hybridization Diagnostic Applications in Tumors;Methods in Molecular Biology;2024

2. Multiplex fluorescence in situ hybridization testing for anaplastic lymphoma kinase and c-ros oncogene 1 gene rearrangements on cytology smears in lung adenocarcinomas: comparative study with formalin-fixed paraffin-embedded sections;Journal of the American Society of Cytopathology;2022-05

3. Neue Aspekte zur Feinnadelpunktion von Lymphknoten;Der Pathologe;2022-01-06

4. Comparison of PD-L1, EGFR, ALK, and ROS1 Status Between Surgical Samples and Cytological Samples in Non-Small Cell Lung Carcinoma;Balkan Medical Journal;2021-09-22

5. Fusion proteins in lung cancer: addressing diagnostic problems for deciding therapy;Expert Review of Anticancer Therapy;2021-03-30